Targeted degradation of α-Synuclein using an evolved botulinum toxin protease

Philipp Sondermann(Scripps Research Institute), Peter G. Schultz(Scripps Research Institute)
Proceedings of the National Academy of Sciences
March 24, 2025
Cited by 3


Related Papers

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
|Proceedings of the National Academy of Sciences|2012|573
Evolution of cyclic peptide protease inhibitors
|Proceedings of the National Academy of Sciences|2011|128